Production & Manufacturing
News
By 2030, OSD Contract Manufacturing Will Be $54.7 Billion
The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion in value by 2030, exhibiting a compound annual growth rate (CAGR) of 6%, according to a market analysis.
As per data, oral solids are the...
News
By 2026, Pharma Contract Manufacturing To Be Worth $130bn
The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as a result of increasing demand for pharmaceuticals, particularly in developing economies. In 2020, the market was estimated to be worth $100 billion.
Market research indicates...
News
Leanings In The Biopharma Contract Manufacturing For 2022
A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of their operations, which has contributed to the $14 billion market for biopharmaceutical contract manufacturing.
Over the next ten years, the investigators predict a very bright...
News
FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US regulators, with a particular focus on rising insulin prices. The Federal Trade Commission (FTC) announced recently that it would step up enforcement against practises...
News
Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production
COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take, for example, Pfizer's new $120 million investment. The company announced on June 6Â that it will use the funds to expand manufacturing of its oral...
IT & Data Management
RCPE and InSilicoTrials to Digitalize and Accelerate the Development of Pharmaceutical Manufacturing Processes
RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software. Specifically developed for pharmaceutical applications, XPS allows companies to assess their process configurations in unprecedented detail and explore the decision space without time- and...
Press Releases
PIPAc Collaboration Enables New Compact, Mobile and Frugal Approach to Active Pharmaceutical Ingredient (API) Manufacturing
The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
